You are on page 1of 4
Un-Audited Financial Results of Quarter Ended Sep . 2015 30-09-2015 of Mis. Biofil Chemicals & Pharmaceuticals Limited 414/12, Sector-"E’ Sanwer Road, Industrial Area, Indore (M.P.) Un AUDITED FINANCIAL RESULTS FOR THE QUARTER AND HALF YEAR ENDED 30th September , 2015 ‘CIN NO. L24233MP1985P1.c002709 [PART (Re: in Latha) (Except EPS & Number of Share) Particulars ‘Quarter Ended. Wald Year Ended — | Vear Ended Sorts | duns ] Sepia | Sapte | Sepa | Marte TRefor Notes Below) Reviwed_| Reviwed | Reviwed | Roviwed | Reviwed | (Audited) 7|inome rom operations (Ga) Net sales! income from operations (Net of Exes Gu) eral TTA] TT B7| var 7] ass] (6) Other operating income 2.70. 318 129.71 Total income from operations (nat) o.10[ 7a7a| ta573] izt76| 86.16 2[Expenses: (a) Cost of matorate consumed 2a76| soa 20.87] 6070 ——3a-16| 00.85) () Purchases of stockade 7250| 1e2e] 1583] 2078] 36 73| 276.27 (6) Changes in inventories of fiieTied goods, workan= prograve and stock-nsvade 225| 622] 25 aan _ arn) 1.95 TG Employes benefits expense CT A ET {@) Depreciation and amorisation @Gense ‘ar erel er] 5] 71) __ancorl Other expenses(Any tam exeseding 10% ofthe Total ‘expenes relating fo continuing operations tobe shown separately) 625| 690] __2170|__ +458] 75.00) Total expenses, ears| e007] e207] i242] 108.86) 697.80] 3]Profit/ (Lose) from oparations before othe Income, |costs and exceptional items (1-2) cea] 9.03 ost] 1201] 4830 cicpenee 2074 : zori| 1463] as.tg 3] Profit (Loss) from ordinary activiios before finance costs land exceptional items (34) 1aso| _903| ta7s| 2162] arse] 4a. Sfaernes 375| are] s75| 77] 750] 20.05] 7]Pront (Lose) from ordinary activities afer finance costs but I toms (8+ 8. os! s31| 1500] 1415| _2004| 73.54 Blexceptiona tems aa B]Promt7 (Lose) from ordinary activities before tax (7 "eau Daas ue na | aan ees To] Taxexpense 140 i Not Profit (Lose) rom ordinary activities after tax (9 70) ere ere eee 72 Minoriy riereat™ 73] Nat profiioss) after taxes minority Intorest and share of profit (loss) of associates (13+14* 15) aes] sat| _1800| _14is| 2008] _sa.72 fe 162728] 2627.38] s67738) 162738] 1627.38| 1627.38 [Face Value of the Share challbe indicated) wl 1 al “ol al a 75] Reserve excluding Revaluation Reserves Saal 1767 [Earnings per share (before extraordinary ems) (oF Re. 107 each) (not annuslised): Ser asa] 0033| 032] __o.os7|__o.3|___0.36 es 054] 0033] 0.092] oos7| os] 0.363 iret [Earnings per share (after extraordinary items) ToFRE 10/-each) not annualised: yeas o0sa] 0.033 0.092| _0.087| poe vse] 0035] aoa] 0.087, way [See accompanying note to the financial result PART Paricaare SopAS | Tunas] Sopte | Sopts | Sapte] wats Taviwed | Raver | Reviwed | Raviwed | Revived) hualiay Ja |rarmicuLaRs oF SHAREHOLDING 4) Pubic sharhoking Number of hares 025100] sssi00] sessioo} sosstoo] ossstoo] 2550] = Percentage of shareholding sore] sare] sate] cate] sae] sae 2| Promoters and Promter Group Sharholing “ 2) Pedged/Encumbered Na sa fo Pom | ow Ni Number of shares Ni na fo Po [ow Ni Percentage of shares a8 % ofthe total sarehoaing off Ni ne fo Po [on i bromotr ane promoter gr) "orcontage of shares a6 3% of tho‘otl share capa of] Nl wn fon Pon | on nu the company) Non encumbered Number f shares e10700] 7618700) 7et8700] 7618700) 7e18700) 7618700 Percentage of shares (asa% ofthe total shareholding off 100] taal 100) taal 0g 109 ‘he rrmotr end Promter ou) “Sercontageofshares (os a ofthe ctalsharecapiaict] 40.02] 4080] 40.8] ase] see] 8 thecompan Parte Toni Je fiwvesror compLaints lrending a te beginning fhe quater Na Received during he qvanter 1 bisposed of dung the quarter 1 JRemairng unresoved at the endo th querer na Teer 1. Above Unaudited Financial Results were reviewed by Audit Committee and approved by ‘Board of Directors in their meeting held on 09th November 2015 2. Figures have been regrouped wherever necessary. 3. The Statuary auditors have carried out a limited review of the result for quarter ended 30th Sep- 2015 pate: 09.11.2015 Cy a Pace: Indore == RAMESH SHAH MANAGING DIRECTOR (ow: 00028818) BIOFIL CHEMICALS & PHARMACEUTICALS LTD. CIN NO. L24233MP1985PLC002709 ‘Segmentwise Revenue, Results an Capital Employed for Quarter and Half year ended 30th Sep 2015 (Under Clause 41 Listing Agreement) Re. In lacs. SNo_ [Segment Revenue ‘Quarter Ended Half Year Ended Sep 30, | Juneso, | Sep30, | Sep30, | Sep30, [91 March 72015 2015) 2014 2015 2014 [2015 Reviewed | Reviewed | Reviewed | Reviewed | Reviewed | Audited T [Segment Revenue 20.09.2018] _ 30-06-2018| 30.08.2014] 30.09.2015] 30.09.2014] 31.03.2015 Pharma Unit 10.68, 1603 20.13 2671] 36.50] 418.30, [Chemicals Divison, 37.98. 42.89] _48.71| 60.67] 103.17] 190.45 Plastic Division 1.52 3.43 2a7| 1000] 38.74 37.40 [other 27.17] 7.70 0.00 | 28.87 2.10 46.19 [Gross Tumover Tr34 wero] 7171] 146.48] t00.52| 632.34 2 [Segment Resuits [Pharma Unit 1125) 321 250] 73%. (248)| 102.66 [Chemicals Division 16.38 ese[ 22e0[ 2ae6] 2t0a| (10.32)| Plastic Division (2.54) e275 asa] 629) 71) .19)| [other 0.00 0.00 0.00 0.00 0.00 1.82 [Total Segment Profit Before Tax 7259 wos[ wave 21es| 1480 34.06 interest income (0.00 0.00, 0100 = 030, interest Expenses 375 372 375 Tar 7.50 20.81 [other Unallocable Income not of Expenditure [Profit Before Tax Ec aa worl 1445 738 7354 Provision for current tax ‘0.00 0.00 3.00 : : 14.01 oat Profit After Tax 531 qs01| 1415 728 38.72 3 [Capital Employed (Segment Assets- Segment Liabilities) Pharma Unit 17666 mo7i| 17606) 24645] 146.02 [Chemicals Division 739.88 440,74| 730.80| 55449] 727.16 Plastic Division (51.88) 25.06)| __61.88)| (15.96) (45.72) [Other = 221)| 0.00 | __(51.55)] 0.00) [Total Capital Employed 364.67 @34.10| 86467] 733.42| 627.46 37.21 DATE : 09-11-2015 BIOFIL CHEMICALS & PHARI PLACE: INDORE a RAMESH SHAH MANAGING DIRECTOR (DIN : 00028819) BIOFIL CHEMICALS & PHARMACEUTICALS Ltd. UN-AUDITED FINANCIAL STATEMENT OF ASSETS AND LIABILITIES AS AT 20-09-2015 CIN NO. L24233MP1985PLC002709 in Ry] ‘landalone / Consolidated Statement of Assets and eat feat Liabilities wor0s2015 Bos/2075 Particulars [A EQUITY & ABILITIES 7|Sharehaiders’ funda (@) Share Capital TERTIBOOO| TEZTSEOOD| (6) Resorvos & Surplus THA75S26 78500525) (0) Money received against share warrants ‘Sub-total - Shareholders funda] SESEzETA| saaTET| 2|Share application money pending allotment 3 [Minority interest = | Non-current labios (@) Long-term borrowings (0) Deferred tax labilies (oad (6) Other long-term fables (@) Long-term provisions Sub-total Non-current Tabities| 3|Currentabiities () Short-term borowings SoTaaast, ZaBOO5DG (b) Trade payables 71694996] 21109002] (¢) Other curent tabiiies 5 = (@) Shorten provisions E6775] ZBOB55S ‘Subsotal_ Current Tabiltes| 32056257] Ba15164 TOTAL - EQUITY AND LIABILITES| THEO aSsT TEBE iB |ASSESTS. 7|Noncurrent assets (@) Fixod assole Tangible Asseais 65163700) OBES ] Goodwill on consoidation= (© Non-current investments (G) Deterred tax assets (net) (@)-Long-ferm loans and advances ‘Other non-current assets Sub total - Non-current assets BaTesTOO| 80576538] 2|Current assets [Current investments liaventovies TBe053a| SEE rade recehabIes 3272694] 36512235] [Cash and cash equivalents 3076712 1276162 [Short-term loans and advances 5453246 3279724 [other current assole 2162957] 72253646 [__—___“sb-otal-Currentassets| 5855747] FEET TsEOTeOST "TS7EERE25] DATE : 09/11/2015 BIOFIL CHEMICALS & PHARMAG! PLACE: INDORE ¢ aS RAMESH SHAH MANAGING DIRECTOR {0IN No. 00028819)

You might also like